Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Scientist

Assoc. Prof. Dr. Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Shandong Cancer Hospital China

Dr. Yuchun Wei is a leading Chinese physician-scientist in the field of oncology and nuclear medicine, currently working at the Shandong Cancer Hospital in Jinan, China. Born on November 22, 1987, she has contributed significantly to developing innovative imaging techniques for cancer diagnosis, staging, and individualized treatment planning. With deep expertise in PET/CT imaging biomarkers, she is committed to advancing precision oncology. 📡🧬

Profile

Scopus

Orcid

🎓 Education

Dr. Wei pursued her academic journey with a strong foundation in both Western and traditional Chinese medicine:

  • Ph.D. in Oncology from Shandong University (2018–2022), mentored by Academician Jinming Yu 🎓
  • Master’s in Oncology from Jinan University (2013–2016), under Prof. Shuanghu Yuan 🔬
  • Bachelor’s in Traditional Chinese and Western Clinical Medicine from Shandong University of Traditional Chinese Medicine (2007–2012) 🌿

💼 Professional Experience

Dr. Wei currently serves as a radiotherapy physician at Shandong Cancer Hospital (2017–present). She has also held several administrative and research leadership roles:

  • Deputy Director, MDT Quality Management Office (2021–2022)
  • Assistant Director, Radioimmunity and Molecular Imaging Room (2020–2021)
    Her clinical expertise is complemented by her operational leadership in multidisciplinary cancer care. 🏥⚕️

🔬 Research Interests

Her research revolves around novel imaging techniques, especially FAPI-based PET/CT imaging, with a focus on early detection, prognosis prediction, and therapy monitoring for cancers such as lung, esophageal, and cervical. Her goal is to refine personalized cancer treatment through quantitative imaging biomarkers. 🔍📊

🏆 Awards & Honors

Dr. Wei has been nominated for multiple research and innovation awards in recognition of her work in molecular imaging and radiation oncology. Her studies have earned significant visibility in top-tier journals (JCR Q1), and she is regarded as a rising star in clinical translational imaging. 🌟

📚 Publications Top Notes: 

Dr. Wei has authored and co-authored over 17 high-impact peer-reviewed papers, most of which appear in JCR Q1 journals. Here are her key publications with direct links and citation highlights:

FAPI Compared with FDG PET/CT for Lung Cancer Diagnosis
Radiology, 2023, IF: 19.7 | Cited by: 33

18F-FAPI PET/CT in Esophageal SCC Response Prediction
J Nucl Med, 2024, IF: 9.1 | Cited by: 12

Early Detection of Radiation-Induced Myocardial Damage
Eur J Nucl Med Mol Imaging, 2023, IF: 10.057 | Cited by: 40

18F-FAPI PET/CT Response in Chemoradiotherapy for ESCC
J Nucl Med, 2023, IF: 11.082 | Cited by: 25

Biodistribution and Targeting of 18F-FAPI-04
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 37

Differentiating Lung Cancer Types via PET/CT
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 31

Baseline Angiogenesis in NSCLC Prognosis
J Transl Med, 2022, IF: 8.44 | Cited by: 19

Differentiating Inflammatory Lung Lesions with FAPI
Eur Radiol, 2023, IF: 5.9 | Cited by: 10

Comparison Study in Mouse Model using PET Imaging
Sci Rep, 2016, IF: 5.228 | Cited by: 50

Radiation-Induced Lung Damage Model in Rats
Front Oncol, 2022, IF: 5.738 | Cited by: 14

Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Published on by Popular Scientist

Dr. Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Resident Physician University Cancer Center Schleswig-Holstein (UCCSH) Germany

Dr. Jan Vorwerk is a distinguished medical researcher and clinician currently serving as a resident physician and clinician scientist at the Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), Germany. With a summa cum laude distinction for his medical doctorate and over five years of advanced medical training across Germany, Canada, and Switzerland, Dr. Vorwerk has made remarkable contributions to hematology and oncology research, particularly in acute myeloid leukemia (AML).

Profile

Scopus

Education 🎓

Dr. Vorwerk completed his Medical Doctorate at the University of Münster, with a groundbreaking thesis on the role of GFI1-36N polymorphism in DNA repair and AML therapy, earning summa cum laude honors. He is also a proud alumnus of the University of Zürich and McMaster University. His rigorous academic journey includes first-class grades in multiple state exams and prestigious scholarships from organizations like the German Academic Scholarship Foundation.

Experience 🏥

Dr. Vorwerk’s professional journey includes significant roles as a scholar at the Jürgen Manchot Foundation and the Interdisciplinary Center for Clinical Research Münster. Currently, he is at the forefront of clinical and molecular research in oncology as a resident physician at UCCSH, where he integrates cutting-edge therapies with patient care.

Research Interests 🔬

Dr. Vorwerk specializes in molecular hematology and oncology, focusing on the genetic and metabolic underpinnings of acute myeloid leukemia (AML). His research explores polymorphisms affecting DNA repair, mitochondrial function, and innovative therapeutic targets like CDK4/6 inhibition in leukemia and multiple myeloma.

Awards 🏆

Dr. Vorwerk has been recognized with numerous accolades, including the “Anne Frank Ambassador Award” for academic excellence and community leadership, the “Abitur Graduate Prize” from North Rhine-Westphalia, and scientific honors like the “Young People’s Award” and multiple international science fair prizes.

Publications Top Notes: 📚

Dr. Vorwerk has authored several impactful publications:

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition. Front Oncol. 2022;12:903691.

Germline single-nucleotide polymorphism GFI1-36N causes alterations in mitochondrial metabolism and leads to increased ROS-mediated DNA damage in AML. Biomedicines. 2025;13:107.

Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to therapy. Blood. 2023;142(25):2175-2191.

 

Patricia Lelo | Health Professions | Women Researcher Award

Published on by Popular Scientist

Dr. Patricia Lelo | Health Professions | Women Researcher Award

Doctor Pediatric Hospital of Kalembelembe Congo, Democratic Republic of the

Dr. Patricia Lelo is a dedicated medical doctor with a master’s in public health and specialized training in infectious diseases, including HIV and tuberculosis. Currently pursuing a Ph.D. in mental health and sickle cell anemia, Dr. Lelo brings years of experience in pediatric care, infectious diseases, and public health research. She is known for her exemplary leadership and contributions to pediatric HIV/AIDS care in the Democratic Republic of Congo (DRC).

Profile

Scopus

Education 🎓

Dr. Lelo has a master’s degree in public health and holds several certifications in infectious diseases management, including specialized training in pediatric HIV and tuberculosis. She is currently advancing her academic career as a Ph.D. candidate, focusing on mental health and sickle cell anemia.

Experience 🏥

Since 2004, Dr. Lelo has served as Executive Deputy Head of the Infectious and Chronic Diseases Department at Kalembelembe Pediatric Hospital in Kinshasa, DRC. Her role includes overseeing care and treatment for children infected with and exposed to HIV/AIDS, managing opportunistic infections, tuberculosis, and sickle cell anemia in children. Additionally, she monitors and evaluates HIV/AIDS care programs and has worked as Assistant Coordinator for the SARA project, an initiative to expand HIV prevention and treatment services across DRC.

Research Interests 🔬

Dr. Lelo’s primary research interests include pediatric HIV, tuberculosis, sickle cell disease, and mental health. She is particularly passionate about improving outcomes for children affected by HIV/AIDS and TB, with a focus on comprehensive care and innovative approaches to disease management.

Awards 🏆

Dr. Lelo’s commitment to pediatric healthcare and infectious disease management has earned her recognition at both national and international levels. She has been a key contributor to training programs and projects that support HIV and TB care in children, underscoring her impactful contributions to global health.

Publications Top Notes:📚

Dr. Lelo has co-authored several peer-reviewed articles on topics such as pediatric HIV, prevention of mother-to-child transmission (PMTCT), and the intersection of mental health with infectious diseases. Here are a few notable publications:

Transition to dolutegravir-based ART in 35 low-and middle-income countries: A global survey of HIV care clinics

Lessons Learned from the Impact of HIV Status Disclosure to Children after First-Line Antiretroviral Treatment Failure in Kinshasa, DR Congo

COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic

HIV Disclosure to Infected Children Involving Peers: A New Take on HIV Disclosure in the Democratic Republic of Congo